image slotstage-preclinical
16:10
Preclinical strategy
The groundwork that decides how quickly a study reaches the clinic.
- Market intelligence & feasibility
- Indication & model selection
- Vendor & academic partnerships
- Strategic consulting
One team handles every step, so nothing waits on a hand-off between vendors.
Our CRO team in Sydney handles feasibility, ethics, regulatory notification, site activation and monitoring, with PK/PD bioanalysis in our own laboratory. One contract, one project lead, one timeline.
From protocol to first participant dosed, with one team accountable.
Site and population feasibility, a budget and a start-up plan for your compound.
Ethics submission, Australian local sponsorship, CTN notification, site contracts and investigational product readiness.
Site activation, participant dosing, clinical monitoring, medical and safety oversight, data management and ongoing study coordination.
Bioanalysis in our Sydney laboratory, PK/PD analysis, followed by integrated study reporting and the final Clinical Study Report (CSR).
Most programmes reach us before first-in-human, but we can pick up a study at any stage of development.
image slotThe groundwork that decides how quickly a study reaches the clinic.
image slotFrom protocol to first participant dosed, with one team accountable for delivery.
image slotScaling a programme beyond the first cohorts, in Australia and across the group.
image slotEvery trial in Australia needs a local sponsor entity and ethics approval before the TGA is notified. We prepare the submissions and manage the timeline around them.
General information about the Australian pathway, not legal or regulatory advice.
image slot
image slotJoin the innovation leaders who trust Diagenta to bring breakthrough therapies to market faster than ever before.
Tell us about your compound and where you are in development. We reply within one business day.
Thank you — your enquiry is with our Sydney team. We will come back to you shortly.